Skip to main content

MJFF Publications

1061 - 1070 of 7616 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Delivery of RNA Therapeutics: The Great Endosomal Escape!
    Journal Name: Nucleic Acid Therapeutics
    Publisher: Mary Ann Liebert Inc
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1089/nat.2022.0004
    Citation Count: 37
  • RESTRICTED
    Title: Diagnosis and Medical Management of Parkinson Disease
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/con.0000000000001152
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/con.0000000000001151
    Best OA location URL:
    Citation Count: 5
  • RESTRICTED
    Title: ECTRIMS 2022 – Poster
    Journal Name: Multiple Sclerosis Journal
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/13524585221123687
    Citation Count: 14
  • RESTRICTED
    Title: Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation
    Journal Name: Drug Discovery Today
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.drudis.2022.06.005
    Best OA location URL:
    Citation Count: 9
  • RESTRICTED
    Title: FDG-PET combined with learning vector quantization allows classification of neurodegenerative diseases and reveals the trajectory of idiopathic REM sleep behavior disorder
    Journal Name: Computer Methods and Programs in Biomedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cmpb.2022.107042
    Citation Count: 12
  • RESTRICTED
    Title: Global, in situ analysis of the structural proteome in individuals with Parkinson’s disease to identify a new class of biomarker
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41594-022-00837-0
    Best OA location URL:
    Citation Count: 16
  • RESTRICTED
    Title: Identification of Drugs Associated with Lower Risk of Parkinson’s Disease Using a Systematic Screening Approach in a Nationwide Nested Case–Control Study
    Journal Name: Clinical Epidemiology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.2147/clep.s381289
    Citation Count: 5
  • RESTRICTED
    Title: Intermuscular coherence as a biomarker of subthalamic nucleus deep brain stimulation efficacy in Parkinson’s disease
    Journal Name: Clinical Neurophysiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clinph.2022.07.489
    Citation Count: 0
  • RESTRICTED
    Title: Issue Overview
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.con.0000892540.33029.c0
    Best OA location URL:
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.